Please note: AABB reserves the right to make updates to this program.
Wednesday, April 29, 2026
2:00 – 3:00 PM Eastern Time
Program Number: 26EL-628
Director/Moderator: Anh Dinh, MD, Assistant Research Physician, National Institutes of Health, Bethesda, MD
Speakers:
Transfusion is one of the greatest expenses in the healthcare system. Given the continual increase in healthcare costs, comprehensive cost analyses are key for proper resource utilization and improved patient outcomes. Transfusion costs extend far beyond the acquisition price of blood products, encompassing critical elements like processing, storage, testing, and the procedural aspects of transfusion itself. Current cost analyses, however, often fall short by excluding these activity-based costs and overlooking external and market-based factors, such as component-specific considerations and blood supply limitations. The goal of this eCast is to highlight the factors that should be considered to promote a deeper understanding of the true cost of transfusion to provide blood in the most sustainable and patient-centered manner.
After participating in this educational activity, participants should be able to:
Registration includes access to both the live and on-demand version of this eCast.
If you are a facility interested in participating in this eCast, simply complete the Group Viewing registration form and AABB will provide detailed instructions to share with your team approximately one week prior to the live program (each team member to register for the program utilizing a promocode). For single viewers, simply click on the Register button below to register.
Please note: registration for the live eCast will close 1 hour prior to the eCast start time. If you register after this time, you will receive access to the on-demand eCast when it is available.
| Single Viewer | Register |
| Group Viewing | Register |
This activity is eligible for one (1) continuing education credit/contact hour for Physicians, California Nurses, California Lab Personnel, Florida Lab Personnel and General Participation credit. AABB reserves the right to reduce or increase the number of credits granted based on the final activity duration. For more information on each credit type please visit our Continuing Education Credits webpage.
There is no financial support for this activity.
In support of improving patient care, this activity has been planned and implemented by the Association for the Advancement of Blood & Biotherapies (AABB), which is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME): AABB designates this live activity for a maximum of one (1) AMA PRA Category 1 CreditTM. AABB designates this enduring activity for a maximum of one (1) AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Claiming Credit
Live Activity - Upon completion of the live activity, you will receive instructions to complete your evaluation, which is necessary to claim credit and receive your certificate of attendance/completion (credit must be claimed by the date provided in the instructions). The evaluation can be found by logging into the AABB Education Platform.
Enduring Activity - Once the enduring (on-demand) program is available, you will receive instructions to access the AABB Education Platform. Upon completion of viewing the enduring activity, you will need to complete the evaluation, which is necessary to claim credit and receive your certificate of completion (credit must be claimed by the date provided in the AABB Education Platform).
Program & Credit Expiration Dates:
Disclosure Declaration
It is the policy of the Association for the Advancement of Blood & Biotherapies to ensure independence, balance, objectivity, and scientific rigor and integrity in all of its CE activities. Faculty must disclose to the participants any relationships with commercial companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. AABB has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that the presence of such relationships will have a negative impact on the presentations.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty, peer reviewers, and AABB personnel are provided at the beginning of the program.
Dr. Brian Adkins earned Bachelor of Science degrees in Biomedical Science and Biological Science at Marshall University. He attended medical school at the Joan C. Edwards School of Medicine at Marshall University, and completed his Anatomic Pathology/Clinical Pathology residency at Vanderbilt University Medical Center. He went on to complete fellowship training in Blood Banking/Transfusion Medicine and Hematopathology at University of Virginia Health. He is board-certified in Anatomic Pathology and Clinical Pathology with subspecialty certification in Blood Banking/Transfusion Medicine and Hematopathology. He serves as Medical Director of Transfusion and Tissues services as well as Coagulation at Children's Health Dallas. He attends as faculty at Children's Health Dallas, Children's Health Legacy, Parkland Memorial Hospital, and Clements University Hospital. His interests include resident and fellow education as well as clinical research.
Dr. Anh Dinh received her BA in Biology from the University of Virginia and her MD from Eastern Virginia Medical School. She completed her clinical pathology residency at Beth Israel Deaconess Medical Center / Harvard Medical School, where she served as Chief Resident. She then completed fellowship training through the Harvard Medical School Fellowship Program in Transfusion Medicine and the Children's Hospital of Philadelphia Histocompatibility and Immunogenetics Fellowship Program. She is board-certified in clinical pathology and blood banking/transfusion medicine and is an Affiliate of the American College of Histocompatibility and Immunogenetics. Dr. Dinh is currently an Assistant Research Physician at the National Institutes of Health (NIH) Clinical Center and serves as the Associate Medical Director and Chief of the Research Practice Development team in the Center for Cellular Engineering in the Department of Transfusion Medicine.
Dr. Jeremy Jacobs is an assistant professor in Transfusion Medicine in the Department of Pathology, Microbiology, & Immunology at Vanderbilt University and Medical Director of the Routine and Esoteric Coagulation Laboratories at Vanderbilt Medical Laboratories and Vanderbilt University Medical Center. He completed his bachelor's degree at Tennessee Tech University, master's degree at Johns Hopkins, clinical pathology residency and transfusion medicine fellowship at Yale School of Medicine and a special coagulation fellowship at the Mayo Clinic. Dr. Jacobs has particular interest in hemostasis-related diagnostics and transfusion support as well as immune-mediated coagulopathies and cytopenias. He has authored over 150 peer-reviewed publications and is actively involved in multiple professional organizations and sits on committees for AABB, ASFA, the International Society of Blood Transfusion, and the American Society for Clinical Pathology. He is currently Chair of the ASFA TTP/TMA Research Sub-Committee and serves on the ASFA Coagulation Research Sub-Committee.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
